Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles.

Russell CJ, Simões EAF, Hurwitz JL.

Viral Immunol. 2018 Mar;31(2):133-141. doi: 10.1089/vim.2017.0137. Epub 2018 Jan 11.

PMID:
29323621
2.

Inflammasome Antagonism by Human Parainfluenza Virus Type 3 C Protein.

Shil NK, Pokharel SM, Banerjee AK, Hoffman M, Bose S.

J Virol. 2018 Jan 30;92(4). pii: e01776-17. doi: 10.1128/JVI.01776-17. Print 2018 Feb 15.

PMID:
29187536
3.

Parainfluenza Virus 3-Specific T Cells: Opportunity for Intervention?

Waghmare A, Englund JA, Boeckh M.

J Infect Dis. 2017 Jul 15;216(2):147-149. doi: 10.1093/infdis/jix207. No abstract available.

PMID:
28472318
4.

Enterovirus D68 Infection Among Children With Medically Attended Acute Respiratory Illness, Cincinnati, Ohio, July-October 2014.

Biggs HM, McNeal M, Nix WA, Kercsmar C, Curns AT, Connelly B, Rice M, Chern SW, Prill MM, Back N, Oberste MS, Gerber SI, Staat MA.

Clin Infect Dis. 2017 Jul 15;65(2):315-323. doi: 10.1093/cid/cix314.

PMID:
28379349
5.

Clinical Features of Human Metapneumovirus Infection in Ambulatory Children Aged 5-13 Years.

Howard LM, Edwards KM, Zhu Y, Griffin MR, Weinberg GA, Szilagyi PG, Staat MA, Payne DC, Williams JV.

J Pediatric Infect Dis Soc. 2018 May 15;7(2):165-168. doi: 10.1093/jpids/pix012.

PMID:
28369564
6.

The potential influence of human parainfluenza viruses detected during hospitalization among critically ill patients in Kuwait, 2013-2015.

Essa S, Al-Tawalah H, AlShamali S, Al-Nakib W.

Virol J. 2017 Feb 3;14(1):19. doi: 10.1186/s12985-017-0681-0.

7.

Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes.

McLaughlin LP, Lang H, Williams E, Wright KE, Powell A, Cruz CR, Colberg-Poley AM, Barese C, Hanley PJ, Bollard CM, Keller MD.

Cytotherapy. 2016 Dec;18(12):1515-1524. doi: 10.1016/j.jcyt.2016.08.010. Epub 2016 Sep 28.

8.
9.

Population-based Surveillance for Medically Attended Human Parainfluenza Viruses From the Influenza Incidence Surveillance Project, 2010-2014.

Steffens A, Finelli L, Whitaker B, Fowlkes A.

Pediatr Infect Dis J. 2016 Jul;35(7):717-22. doi: 10.1097/INF.0000000000001140.

10.

Viral protein requirements for assembly and release of human parainfluenza virus type 3 virus-like particles.

Bracken MK, Hayes BC, Kandel SR, Scott-Shemon D, Ackerson L, Hoffman MA.

J Gen Virol. 2016 Jun;97(6):1305-10. doi: 10.1099/jgv.0.000449. Epub 2016 Mar 9.

11.

Estimates of Parainfluenza Virus-Associated Hospitalizations and Cost Among Children Aged Less Than 5 Years in the United States, 1998-2010.

Abedi GR, Prill MM, Langley GE, Wikswo ME, Weinberg GA, Curns AT, Schneider E.

J Pediatric Infect Dis Soc. 2016 Mar;5(1):7-13. doi: 10.1093/jpids/piu047. Epub 2014 Jun 2.

12.

Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses.

Russell CJ, Hurwitz JL.

Expert Rev Vaccines. 2016;15(2):189-200. doi: 10.1586/14760584.2016.1114418. Epub 2015 Dec 9. Review.

13.

Evaluation of a Live-Attenuated Human Parainfluenza Type 1 Vaccine in Adults and Children.

Karron RA, San Mateo J, Thumar B, Schaap-Nutt A, Buchholz UJ, Schmidt AC, Bartlett EJ, Murphy BR, Collins PL.

J Pediatric Infect Dis Soc. 2015 Dec;4(4):e143-6. doi: 10.1093/jpids/piu104. Epub 2014 Nov 12.

14.

Parainfluenza Virus Infection Among Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Children and Adults Hospitalized for Severe Acute Respiratory Illness in South Africa, 2009-2014.

Cohen AL, Sahr PK, Treurnicht F, Walaza S, Groome MJ, Kahn K, Dawood H, Variava E, Tempia S, Pretorius M, Moyes J, Olorunju SA, Malope-Kgokong B, Kuonza L, Wolter N, von Gottberg A, Madhi SA, Venter M, Cohen C.

Open Forum Infect Dis. 2015 Sep 19;2(4):ofv139. doi: 10.1093/ofid/ofv139. eCollection 2015 Dec.

15.

Cross-immunity between strains explains the dynamical pattern of paramyxoviruses.

Bhattacharyya S, Gesteland PH, Korgenski K, Bjørnstad ON, Adler FR.

Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13396-400. doi: 10.1073/pnas.1516698112. Epub 2015 Oct 12.

16.

Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children.

Waghmare A, Wagner T, Andrews R, Smith S, Kuypers J, Boeckh M, Moss R, Englund JA.

J Pediatric Infect Dis Soc. 2015 Jun;4(2):114-8. doi: 10.1093/jpids/piu039. Epub 2014 May 14.

17.

Respiratory Viral Detections During Symptomatic and Asymptomatic Periods in Young Andean Children.

Howard LM, Johnson M, Williams JV, Zhu Y, Gil AI, Edwards KM, Griffin MR, Lanata CF, Grijalva CG; RESPIRA-PERU Group.

Pediatr Infect Dis J. 2015 Oct;34(10):1074-80. doi: 10.1097/INF.0000000000000812.

18.

Unity in diversity: shared mechanism of entry among paramyxoviruses.

Palgen JL, Jurgens EM, Moscona A, Porotto M, Palermo LM.

Prog Mol Biol Transl Sci. 2015;129:1-32. doi: 10.1016/bs.pmbts.2014.10.001. Epub 2014 Dec 1. Review.

19.

Human rhinovirus C infections in pediatric hematology and oncology patients.

Loria C, Domm JA, Halasa NB, Heitman E, Miller EK, Xu M, Saville BR, Frangoul H, Williams JV.

Pediatr Transplant. 2015 Feb;19(1):94-100. doi: 10.1111/petr.12383. Epub 2014 Nov 6.

20.

Wheat germ cell-free system-based production of hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 for generation and characterization of monoclonal antibody.

Matsunaga S, Kawakami S, Matsuo I, Okayama A, Tsukagoshi H, Kudoh A, Matsushima Y, Shimizu H, Okabe N, Hirano H, Yamamoto N, Kimura H, Ryo A.

Front Microbiol. 2014 May 13;5:208. doi: 10.3389/fmicb.2014.00208. eCollection 2014.

Supplemental Content

Support Center